Sarepta Therapeutics (SRPT - Get Report) is a biopharmaceutical company focused on the discovery and development of RNA-based therapeutics for the treatment of both rare and infectious diseases. This stock is trading up 16% at $12.53 in recent trading.
Today's Volume: 2.4 millionAverage Volume: 888,214 Volume % Change: 325% Shares of SRPT are ripping higher today after ThinkEquity initiated coverage on the stock with a buy rating and a $15 price target. >>5 Stocks Poised for Breakouts From a technical perspective, SRPT is exploding higher here with above average volume, and this stock has entered breakout territory since it's moved above some near-term overhead resistance at $10.78. Traders should now look for long-biased trades as long as SRPT is trending above that breakout level of $10.78 or today's low of $11.65 with strong upside volume flows. I would consider any upside volume day that registers near or above 888,214 shares as bullish. If we continue to see that action, then SRPT has a great chance of hitting $15 in the near future. Cornerstone OnDemand
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts